Future Oncology

JournalCitation impact & published research

Future Oncology is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 5,641 works, 99,231 citations and an h-index of 111.

5,641

Works

99,231

Citations

111

h-index

IDs:OpenAlex

What are the most-cited papers on Future Oncology?

ScholarIQmost cited works

USA Endometrial Cancer Projections to 2030: Should we be Concerned?

Maryam Sheikh, Andrew D. Althouse, Kyle E. Freese, Sean Soisson, Robert P. Edwards, Sharon C. Welburn, Paniti Sukumvanich, John T. Comerci, Joseph L. Kelley, Ronald E. LaPorte, Faina Linkov

Future Oncology. 2014244 Citations

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma

Qian Zhou, Vivian Wai Yan Lui, Winnie Yeo

Future Oncology. 2011215 Citations

Plasma YKL-40: A Potential New Cancer Biomarker?

Julia S. Johansen, Nicolai A. Schultz, Benny Vittrup Jensen

Future Oncology. 2009168 Citations

Epidemiology, Clinical Manifestations, Risk Reduction and Treatment Strategies of Jaw Osteonecrosis in Cancer Patients Exposed to Antiresorptive Agents

Giuseppina Campisi, Stefano Fedele, Vittorio Fusco, Giuseppe Pizzo, Olga Di Fede, Alberto Bedogni

Future Oncology. 2014145 CitationsOPEN ACCESS

Novel Therapeutic Approaches in Chondrosarcoma

Genovefa Polychronidou, Vasilios Karavasilis, Seth M. Pollack, Paul H. Huang, Alex Pui‐Wai Lee, Robin L. Jones

Future Oncology. 2017127 CitationsOPEN ACCESS

Related on ScholarIQ

USA Endometrial Cancer Projections to 2030: Should we be Concerned?

Paper

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma

Paper

Plasma YKL-40: A Potential New Cancer Biomarker?

Paper

Epidemiology, Clinical Manifestations, Risk Reduction and Treatment Strategies of Jaw Osteonecrosis in Cancer Patients Exposed to Antiresorptive Agents

Paper

Novel Therapeutic Approaches in Chondrosarcoma

Paper

Role of The Epstein–Barr Virus-Encoded Latent Membrane Protein-1, LMP1, in The Pathogenesis of Nasopharyngeal Carcinoma

Paper